藏族脐带间充质干细胞外泌体在低氧性肺动脉高压治疗中的作用及其机制研究
批准号:
32060207
项目类别:
地区科学基金项目
资助金额:
37.0 万元
负责人:
马兰
依托单位:
学科分类:
特殊环境生理与比较生理学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
马兰
中文摘要
干细胞及其外泌体已成为肺动脉高压细胞治疗的研究热点。前期研究结果发现,藏族对低氧环境具有独特的遗传适应机制和最佳适应能力,因此其间充质干细胞在低氧病理微环境中发挥的治疗作用可能有着一定优势。基于此,本课题拟采取青藏高原世居健康藏族和移居汉族新生儿脐带,原代分离培养和鉴定脐带间充质干细胞(UCMSCs)并提取其外泌体,首先进行生物学特性和高通量miRNA测序的比较分析;然后在低压氧舱内构建低氧性肺动脉高压(HPH)动物模型,并给予两组人群UCMSCs外泌体干预后观察其疗效;最后在细胞水平上,分别对低氧诱导的人肺动脉内皮细胞及肺动脉平滑肌细胞进行UCMSCs外泌体干预,进一步观察藏族UCMSCs外泌体对低氧诱导的人肺动脉内皮细胞间质化及肺动脉平滑肌细胞增殖的影响,以期阐明藏族UCMSCs外泌体在HPH肺血管重建中的治疗作用并探讨其可能的机制,从而为今后HPH的干细胞外泌体治疗提供理论依据。
英文摘要
Stem cells and their exosomes have become a hot topic in the treatment of pulmonary artery hypertension cells. Our previous research results showed that Tibetan have their unique genetic adaptation mechanism and best adaptability to hypoxic environment. So the therapeutic effect of their mesenchymal stem cells in hypoxic pathological microenvironment may have some advantages. Base on this, this project plan to use the umbilical cord of healthy Tibetan and immigrated Han nationalities living in the Qinghai Tibet Plateau to carry out the primary isolation, culture and identification of umbilical cord mesenchymal stem cells (UCMSCs), and extract its exosomes. Firstly, the comparative analysis of biological characteristics and high-throughput miRNA sequencing will be carried out. Then, the HPH animal models will be constructed in the hypobaric oxygen chamber, and the therapeutic effects of umbilical cord mesenchymal stem cells-derived exosomes of the two groups are observed after intervention through caudal vein injection. Finally, at the cell level, the human pulmonary vascular endothelial cells and pulmonary artery smooth muscle cells are intervened by Tibetan umbilical cord mesenchymal stem cells-derived exosomes, and the effects of umbilical cord mesenchymal stem cells-derived exosomes on hypoxia induced pulmonary vascular endothelial cells endothelial-to-mesenchymal transition and smooth muscle cell proliferation will be further observed. The purpose of this study is to clarify the therapeutic effect of Tibetan umbilical cord mesenchymal stem cells-derived exosomes in HPH treatment and to explore the possible mechanism, so as to provide a theoretical basis for stem cell therapy of HPH in the future.
肺血管重塑是低氧性肺动脉高压(HPH)形成的重要病理生理基础,肺动脉平滑肌细胞和肺动脉内皮细胞的异常分化、增殖和迁移在肺血管重构中发挥着重要的作用。近年来间充质干细胞及其外泌体在再生医学中的应用前景广阔,人脐带间充质干细胞(hUCMSCs)因其易于获取、增殖能力强等优势,成为细胞治疗和再生医学的首选。目前, 国内外有关脐带间充质干细胞对HPH治疗作用的研究报道甚少且机制不明确。而有着最佳低氧适应能力的藏族UCMSCs在人体内的低氧病理微环境中可能比汉族人更能适应低氧微环境,并持续发挥其旁分泌作用。因此,本项目旨在探讨藏族UCMSCs外泌体在HPH肺血管重建中的治疗作用并探讨其可能的机制。. 我们采用青藏高原世居藏族和移居汉族脐带间充质干细胞源外泌体(UCMSC-Exo)通过高通量miRNA测序的比较分析,发现藏族和汉族UCMSC-Exo之间存在差异表达的miRNA,且这些差异表达的miRNA与细胞增殖、凋亡等信号通路有关。接着,我们在动物体内水平上进一步观察其干预作用,结果发现,藏族和汉族UCMSC-Exo能够明显缓解HPH肺血管重塑的形成,且藏族UCMSC-Exo效果优于汉族UCMSC-Exo。然后,我们在体外水平上进一步观察了藏族和汉族UCMSC-Exo对低氧诱导的肺动脉平滑肌细胞(PASMCs)和肺动脉内细胞(PAECs)的增殖、迁移的影响及其机制。结果发现,UCMSC-Exo能够显著抑制低氧诱导的HPAECs和HPAECs的增殖、迁移,且藏族UCMSC-Exo效果优于汉族UCMSC-Exo。进一步通过转录组测序发现,NBL1在藏族UCMSC-Exo干预PASMCs后显著上调,而NBL1的上调引起TGFβ1的表达下调。因此,藏族hUCMSC-Exo延缓HPH肺血管重塑的机制可能与肺血管中TGFβ1/Smad2/3信号通路的下调有关。此外,我们的研究还发现,hUCMSCs-Exo还可以通过调节巨噬细胞极化状态,即将M1型巨噬细胞极化为M2型巨噬细胞降低促炎因子表达,升高抗炎因子分泌改善肺功能及肺部炎症微环境从而延缓HPH肺血管重塑的形成。这一研究成果为今后HPH的干细胞外泌体治疗提供了理论依据。
藏族脐带间充质干细胞外泌体miRNA-203a-3p靶向调控NBL1延缓低氧性肺血管重塑的机制研究
-
批准号:32560216
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:马兰
-
依托单位:
miR-34a在低氧性肺动脉高压肺血管重构中的作用及机制研究
-
批准号:31560292
-
项目类别:地区科学基金项目
-
资助金额:42.0万元
-
批准年份:2015
-
负责人:马兰
-
依托单位:
国内基金
海外基金